Literature DB >> 12008167

Predictors of door-to-balloon delay in primary angioplasty.

Brad G Angeja1, C Michael Gibson, Richard Chin, Paul D Frederick, Nathan R Every, Allan M Ross, Gregg W Stone, Hal V Barron.   

Abstract

In the treatment of acute myocardial infarction, delayed reperfusion therapy is associated with increased mortality. Predictors of delay have been described for fibrinolysis but not for primary percutaneous transluminal coronary angioplasty (pPTCA). Therefore, we studied 40,017 consecutive patients with acute myocardial infarction who underwent pPTCA in the National Registry of Myocardial Infarction between June 1994 and April 2000. Median door-to-balloon times were calculated, and factors independently associated with a delay of >120 minutes were determined by logistic regression. The median door-to-balloon time among all patients was 111 minutes (interquartile range 84 to 152). The proportion of patients with a delay of >2 hours was greater among those aged > or = 65 years (49% vs 41%), women (50% vs 42%), patients with contraindications to fibrinolysis (60% vs 41%), and those without chest pain on admission (61% vs 43%, all p <0.0001). Delay was also more common with transfer from another hospital (87% vs 38%), with presentation outside the hours of 8 A.M. to 4 P.M. (51% vs 38%), and in hospitals performing <49 pPTCAs/year (47% vs 41%, all p <0.0001). The strongest independent predictor of delay was hospital transfer, along with non-daytime presentation and low-volume centers. Older age, female sex, and non-white race were weaker predictors. Both patient and hospital factors are associated with delay in pPTCA after presentation. These findings may help design treatment algorithms to minimize delay, thus improving the survival benefit of pPTCA. These results may also help design trials of combination reperfusion strategies.

Entities:  

Mesh:

Year:  2002        PMID: 12008167     DOI: 10.1016/s0002-9149(02)02296-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  25 in total

Review 1.  Tailoring therapy to best suit ST-segment elevation myocardial infarction: searching for the right fit.

Authors:  Paul W Armstrong; Robert C Welsh
Journal:  CMAJ       Date:  2003-10-28       Impact factor: 8.262

2.  Facts and principles learned at the 32nd annual Williamsburg Conference on Heart Disease.

Authors:  William Clifford Roberts; Hassan Farooq
Journal:  Proc (Bayl Univ Med Cent)       Date:  2005-04

3.  Not all ST-segment elevation myocardial infarctions become Q-wave myocardial infarctions.

Authors:  D Luke Glancy; Eleanor J Daveron; Suresh P Jain
Journal:  Proc (Bayl Univ Med Cent)       Date:  2002-10

4.  Myocardial infarction symptom recognition by the lay public: the role of gender and ethnicity.

Authors:  Pamela A Ratner; Roula Tzianetas; Andrew W Tu; Joy L Johnson; Martha Mackay; Christopher E Buller; Maureen Rowlands; Birgit Reime
Journal:  J Epidemiol Community Health       Date:  2006-07       Impact factor: 3.710

Review 5.  Delivery of primary percutaneous coronary intervention for the management of acute ST segment elevation myocardial infarction: summary of the Cardiac Care Network of Ontario Consensus Report.

Authors:  Marino Labinaz; Terri Swabey; Randal Watson; Madhu Natarajan; Wendy Fucile; Bruce Lubelsky; Bruce Sawadsky; Eric Cohen; Kevin Glasgow
Journal:  Can J Cardiol       Date:  2006-03-01       Impact factor: 5.223

6.  Influence of presentation at the weekend on treatment and outcome in ST-elevation myocardial infarction in hospitals with catheterization laboratories.

Authors:  Patricia Krüth; Uwe Zeymer; Anselm Gitt; Claus Jünger; Harm Wienbergen; Franz Niedermeier; Hans-Georg Glunz; Jochen Senges; Ralf Zahn
Journal:  Clin Res Cardiol       Date:  2008-05-08       Impact factor: 5.460

7.  Quality measure study: progress in reducing the door-to-balloon time in patients with ST-segment elevation myocardial infarction.

Authors:  Katsufumi Nishida; Sean K Hirota; Todd B Seto; Daniel C Smith; Cathy Young; Wanda Muranaka; Suzanne Beauvallet; David Fergusson
Journal:  Hawaii Med J       Date:  2010-10

8.  Sex differences in reperfusion in young patients with ST-segment-elevation myocardial infarction: results from the VIRGO study.

Authors:  Gail D'Onofrio; Basmah Safdar; Judith H Lichtman; Kelly M Strait; Rachel P Dreyer; Mary Geda; John A Spertus; Harlan M Krumholz
Journal:  Circulation       Date:  2015-03-19       Impact factor: 29.690

9.  Association of door-to-balloon time and mortality in patients > or =65 years with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.

Authors:  Saif S Rathore; Jeptha P Curtis; Brahmajee K Nallamothu; Yongfei Wang; JoAnne Micale Foody; Mikhail Kosiborod; Frederick A Masoudi; Edward P Havranek; Harlan M Krumholz
Journal:  Am J Cardiol       Date:  2009-11-01       Impact factor: 2.778

Review 10.  Diagnosing and characterizing coronary artery disease in women: developments in noninvasive and invasive imaging techniques.

Authors:  Vivian G Ng; Stephanie Meller; Suchith Shetty; Alexandra J Lansky
Journal:  J Cardiovasc Transl Res       Date:  2013-08-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.